Xylapan 20 mg/ml Solution for Injection

Riik: Iirimaa

keel: inglise

Allikas: HPRA (Health Products Regulatory Authority)

Toimeaine:

Xylazine

Saadav alates:

Vetoquinol UK Limited

ATC kood:

QN05CM92

INN (Rahvusvaheline Nimetus):

Xylazine

Annus:

20 milligram(s)/millilitre

Ravimvorm:

Solution for injection

Retsepti tüüp:

VPO: Veterinary Practitioner Only as defined in relevant national legislation

Terapeutiline rühm:

Cats, Cattle, Dogs, Horses

Terapeutiline ala:

xylazine

Näidustused:

Neurological Preparations

Volitamisolek:

Authorised

Loa andmise kuupäev:

2000-10-01

Toote omadused

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Xylapan 20 mg/ml Solution for Injection.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Solution for injection.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle, horse, dog and cat.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
All cases where sedation is required in cattle, horses, dogs and cats
including:
1.
Handling fractious animals, e.g. for transportation.
2.
Medical examinations, e.g. x-ray examination, removal of bandages,
examination of the teats, penis and oral cavity.
3.
Premedication for minor superficial operations, painful manipulative
procedures and local or regional anaesthesia.
4.
Elimination of defaecation when examining and treating the vagina,
uterus and hindquarters.
4.3 CONTRAINDICATIONS
Do not use:
•
in cases of known hypersensitivity to the active ingredient.
•
in the latter stages of pregnancy except at parturition.
•
when pulmonary disease is present or suspected.
•
in mechanical complications of the alimentary tract in the cat and dog
such as obstruction of the oesophagus, torsion
of the stomach, or hernia.
•
in cases of diabetes mellitus.
Each ml contains:
ACTIVE SUBSTANCE(S)*
Xylazine (as hydrochloride)
20.0 mg
EXCIPIENT(S)*
Methyl Parahydroxybenzoate (E218)
0.65 mg
Propyl Parahydroxybenzoate (E216)
0.35 mg
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_2_
_4_
_/_
_0_
_6_
_/_
_2_
_0_
_1_
_6_